ArticleResuscitation plus2026
Wolf Creek XVIII Part 6: transforming clinical trial design in cardiac arrest research.
Article in Resuscitation plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Wolf Creek XVIII Part 1: advancing resuscitation science.Resuscitation plus · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 50th Anniversary Wolf Creek XVIII Conference was hosted by the Max Harry Weil Institute for Critical Care Research and Innovation in Ann Arbor, Michigan, USA on June 19-21, 2025. "Transforming Clinical Trial Design in Cardiac Arrest Research" was a topic of focused presentation and discussion. Participants included invited panelists and conference attendees made up of international academic and industry scientists as well as thought leaders in the field of cardiac arrest resuscitation. Panelists identified six key opportunities to transform clinical trial design: (1) Selecting the "right" patient and intervention, (2) Optimizing randomization, (3) Measuring relevant and unbiased outcomes, (4) Designing alternative approaches to "usual" randomize controlled trials (RCTs), (5) Maintaining public trust and engagement, and (6) Changing the approach to knowledge translation from research into clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.